304 related articles for article (PubMed ID: 32453819)
1. Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.
Pepe J; Body JJ; Hadji P; McCloskey E; Meier C; Obermayer-Pietsch B; Palermo A; Tsourdi E; Zillikens MC; Langdahl B; Ferrari S
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32453819
[TBL] [Abstract][Full Text] [Related]
2. Management of osteoporosis in a pre-menopausal woman.
Bhalla AK
Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):313-27. PubMed ID: 20534366
[TBL] [Abstract][Full Text] [Related]
3. Anabolic and antiresorptive therapy for osteoporosis: combination and sequential approaches.
Cosman F
Curr Osteoporos Rep; 2014 Dec; 12(4):385-95. PubMed ID: 25341476
[TBL] [Abstract][Full Text] [Related]
4. Management of low bone mineral density in premenopausal women.
Khan A
J Obstet Gynaecol Can; 2005 Apr; 27(4):345-9. PubMed ID: 15937608
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center.
Cohen A; Fleischer J; Freeby MJ; McMahon DJ; Irani D; Shane E
J Womens Health (Larchmt); 2009; 18(1):79-84. PubMed ID: 19132880
[TBL] [Abstract][Full Text] [Related]
6. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
7. Premenopausal women and low bone density.
Khan A
Can Fam Physician; 2006 Jun; 52(6):743-7. PubMed ID: 16812966
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis in premenopausal women.
Langdahl BL
Curr Opin Rheumatol; 2017 Jul; 29(4):410-415. PubMed ID: 28394826
[TBL] [Abstract][Full Text] [Related]
9. Preoperative bone health assessment and optimization in spine surgery.
Anderson PA; Kadri A; Hare KJ; Binkley N
Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805
[TBL] [Abstract][Full Text] [Related]
10. Premenopausal bone health: osteoporosis in premenopausal women.
Abraham A; Cohen A; Shane E
Clin Obstet Gynecol; 2013 Dec; 56(4):722-9. PubMed ID: 24022503
[TBL] [Abstract][Full Text] [Related]
11. Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise.
Binkley N; Besuyen R; Fuerst T; Skillern L; Hans D
Osteoporos Int; 2017 Dec; 28(12):3501-3513. PubMed ID: 29018923
[TBL] [Abstract][Full Text] [Related]
12. Low-energy fractures without low T-scores characteristic of osteoporosis: a possible bone matrix disorder.
Malluche HH; Porter DS; Mawad H; Monier-Faugere MC; Pienkowski D
J Bone Joint Surg Am; 2013 Oct; 95(19):e1391-6. PubMed ID: 24088974
[TBL] [Abstract][Full Text] [Related]
13. Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.
Cohen A; Recker RR; Lappe J; Dempster DW; Cremers S; McMahon DJ; Stein EM; Fleischer J; Rosen CJ; Rogers H; Staron RB; Lemaster J; Shane E
Osteoporos Int; 2012 Jan; 23(1):171-82. PubMed ID: 21365462
[TBL] [Abstract][Full Text] [Related]
14. Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO).
Silva BC; Madeira M; d'Alva CB; Maeda SS; de Holanda NCP; Ohe MN; Szejnfeld V; Zerbini CAF; de Paula FJA; Bandeira F
Arch Endocrinol Metab; 2022 Nov; 66(5):591-603. PubMed ID: 36191263
[TBL] [Abstract][Full Text] [Related]
15. Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature.
Vescovi JD; Jamal SA; De Souza MJ
Osteoporos Int; 2008 Apr; 19(4):465-78. PubMed ID: 18180975
[TBL] [Abstract][Full Text] [Related]
16. Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis.
Szafors P; Che H; Barnetche T; Morel J; Gaujoux-Viala C; Combe B; Lukas C
Osteoporos Int; 2018 Nov; 29(11):2389-2397. PubMed ID: 29909470
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
[TBL] [Abstract][Full Text] [Related]
18. Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes.
Boonen S; Haentjens P; Vandenput L; Vanderschueren D
J Intern Med; 2004 Jan; 255(1):1-12. PubMed ID: 14687233
[TBL] [Abstract][Full Text] [Related]
19. [To where and until when handle the osteoporosis?].
Uebelhart B; Ferrari S
Rev Med Suisse; 2017 Apr; 13(559):859-862. PubMed ID: 28727344
[TBL] [Abstract][Full Text] [Related]
20. Treatment of bone fragility in patients with diabetes: antiresorptive versus anabolic?
Shah M; Appuswamy AV; Rao SD; Dhaliwal R
Curr Opin Endocrinol Diabetes Obes; 2021 Aug; 28(4):377-382. PubMed ID: 34010225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
